Atrophic rhinitis , give flow charts if possible

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching PubMed

"atrophic rhinitis" treatment

I now have comprehensive information from multiple ENT textbooks. Let me compile a thorough answer with flow charts.

Atrophic Rhinitis

Definition

Atrophic rhinitis is a chronic nasal condition characterized by progressive atrophy of the nasal mucosa, submucosa, mucosal glands, and the underlying turbinate bone. The nasal cavity becomes paradoxically enlarged, yet the patient feels persistent nasal obstruction.
It is also called rhinitis sicca or ozena (when associated with the characteristic foul smell).

Classification

ATROPHIC RHINITIS
       |
  _____|_____
  |         |
PRIMARY   SECONDARY
  |         |
  |         +-- Granulomatous disease (TB, syphilis, rhinoscleroma)
  |         +-- Excessive sinonasal surgery (→ Empty Nose Syndrome)
  |         +-- Trauma / radiation therapy
  |         +-- Chronic rhinosinusitis
  |         +-- Rhinitis medicamentosa
  |
  +-- Idiopathic (developing countries, subtropical/temperate zones)
  +-- Associated with Klebsiella ozaenae and other bacteria
  +-- Predominantly in women

Etiology of Primary Atrophic Rhinitis

The exact etiology remains unclear, but the following factors are implicated:
CategoryDetails
BacterialKlebsiella ozaenae (most associated), Staphylococcus aureus, Proteus mirabilis, Escherichia coli
GeographicalMost prevalent in developing countries, subtropical and temperate climates
DemographicsPredominantly females
NutritionalIron deficiency, vitamin A/D deficiency proposed
HereditaryPossible genetic predisposition

Pathophysiology Flowchart

Initiating factors (infection/nutritional/genetic)
              |
              v
  Endarteritis obliterans (obliteration of
  blood vessels in nasal submucosa)
              |
              v
  Ischemia of nasal mucosa and turbinate bone
              |
              v
  Glandular atrophy → loss of serous/mucous secretions
  Squamous metaplasia → replacement of ciliated
  pseudostratified columnar epithelium
              |
              v
  Loss of mucociliary clearance
              |
     __________|__________
     |                   |
Turbinate bone         Secretions
   resorption         accumulate and
   (atrophy)          desiccate
     |                   |
Enlarged nasal         Thick, green-yellow
  cavities             to gray crusts form
     |                   |
Paradoxical nasal    Foul smell (ozena)
  obstruction        + anosmia
  • Cummings Otolaryngology, p. 892
  • K.J. Lee's Essential Otolaryngology, p. 579
  • Scott-Brown's Otorhinolaryngology Vol 1, p. 486

Histopathology

Key features:
  • Squamous metaplasia of the pseudostratified ciliated columnar epithelium
  • Glandular atrophy - loss of goblet cells and seromucinous glands
  • Diffuse endarteritis obliterans - obliteration of submucosal blood vessels
  • Fibrosis of the lamina propria
  • Bone resorption of the turbinates

Clinical Features

Symptoms

SymptomDescription
Nasal crustingThick, yellow-green or gray crusts
OzenaCharacteristic foul smell (often unnoticed by patient due to anosmia)
Anosmia / hyposmiaLoss of smell from mucosal atrophy
Nasal obstructionParadoxical - cavity is enlarged but patient feels blocked
Nasal drynessSevere dryness due to gland loss
EpistaxisFrom ulceration under crusts
CacosmiaPatient senses bad smell

Signs (on examination)

  • Wide nasal cavities bilaterally
  • Greenish-yellow crusts lining the nasal cavity
  • Atrophied, shrunken turbinates
  • Pale, dry nasal mucosa
  • Perforation of nasal septum (in advanced cases)

Diagnostic Approach Flowchart

Patient presents with nasal crusting, congestion,
foul smell, dryness, anosmia
              |
              v
  Detailed history
  - Duration, severity
  - Prior nasal surgery / trauma / radiation?
  - Drug use (topical decongestants)?
  - Granulomatous disease?
              |
              v
  Anterior rhinoscopy / nasal endoscopy
  - Wide nasal cavities
  - Turbinate atrophy
  - Thick crusts
              |
              v
  Is there an identifiable secondary cause?
         /         \
       YES          NO
        |            |
        v            v
  Secondary      Primary Atrophic
  Atrophic       Rhinitis (diagnosis
  Rhinitis       of exclusion)
        |
   _____|______________________
   |          |          |     |
Surgery   Granulo-   Trauma  Rhinitis
cause     matous     /XRT    medicamentosa
          disease
              |
              v
  Investigations:
  - Nasal swab culture (K. ozaenae, S. aureus, Proteus)
  - CBC (iron deficiency anemia)
  - Serum iron, ferritin, Vitamin A
  - CT paranasal sinuses (turbinate atrophy, extent)
  - Histopathology (squamous metaplasia, endarteritis obliterans)
  - ANCA / ACE (if granulomatous disease suspected)

CT Findings

  • Bilateral widening of nasal cavities
  • Atrophy / absence of turbinates (especially inferior turbinate)
  • Mucosal thickening with crusting density
  • Opacification of paranasal sinuses possible

Management Flowchart

Confirmed Atrophic Rhinitis
              |
   ___________|___________
   |                     |
CONSERVATIVE           SURGICAL
(Primary treatment)    (Refractory/severe cases)
   |
   |
   +-- NASAL IRRIGATION (cornerstone)
   |   - Hypertonic (3%) saline lavage
   |   - Removes crusts, hydrates mucosa
   |   - Twice daily minimum
   |
   +-- MOISTURIZING AGENTS
   |   - 25% glucose in glycerine drops
   |   - Nasal lubricants / oil-based drops
   |   - Steam inhalation, humidification
   |
   +-- ANTIMICROBIALS (culture-directed)
   |   - Rifampicin (K. ozaenae) - systemic
   |   - Topical antibiotic sprays
   |   - Chloramphenicol nasal drops (historical)
   |   - Ciprofloxacin (if K. ozaenae sensitive)
   |
   +-- NUTRITIONAL SUPPLEMENTS
   |   - Iron supplements (if deficient)
   |   - Vitamin A, D, E supplementation
   |
   +-- TOPICAL ESTROGENS
       - Oestradiol nasal drops
       - Promotes mucosal regeneration
       - Limited evidence

Surgical Options

Surgical Management (if conservative fails)
              |
     _________|_________
     |                 |
NARROWING PROCEDURES  REGENERATIVE / EXPERIMENTAL
     |                 |
     |                 +-- Autologous fat injection (lipoaspirate)
     |                 +-- Platelet-rich plasma (PRP) injection*
     |                 +-- Autologous costal cartilage turbinate reconstruction
     |
     +-- Young's operation (1967 - classic)
     |   - Bilateral surgical closure of nostrils
     |   - Reduces airflow → mucosal regeneration
     |   - Nostrils reopened after 6 months
     |   - High success but poor patient compliance
     |
     +-- Modified Young's operation
     |   - Partial closure (leaves small opening)
     |   - Better patient tolerance
     |
     +-- Submucosal filler injection
     |   - Paraffin, teflon, cartilage - to narrow cavity
     |
     +-- Inferior turbinate reconstruction
         - Submucosal implants to augment shrunken turbinate
*A 2025 systematic review (Asiry et al., PMID 40820344) reviewed PRP injection for atrophic rhinitis and found promising early results for mucosal regeneration.

Summary Comparison: Primary vs. Secondary

FeaturePrimarySecondary
PrevalenceDeveloping countriesDeveloped countries
SeveritySevere, progressiveMilder, less progressive
CauseUnknown (bacterial?)Known (surgery, trauma, XRT, granuloma)
OrganismsK. ozaenae, S. aureus, ProteusVariable
TreatmentConservative + surgicalTreat underlying cause + conservative

Atrophic Rhinitis vs. Empty Nose Syndrome

These are considered separate entities:
  • Atrophic rhinitis: primary mucosal degeneration with or without prior surgery
  • Empty nose syndrome (ENS): paradoxical obstruction specifically after excessive turbinate removal; associated with significant psychological distress and depression (supported by a 2025 meta-analysis, Shah et al., PMID 40617870)
  • K.J. Lee's Essential Otolaryngology, p. 579
  • Cummings Otolaryngology, p. 892
  • Scott-Brown's Otorhinolaryngology Vol 1, p. 486-499
This is a shared conversation. Sign in to Orris to start your own chat.